| scholarly article | Q13442814 |
| P50 | author | Napoleone Ferrara | Q1769254 |
| Zena Werb | Q20642782 | ||
| P2093 | author name string | Ke Wang | |
| Nathalie Ortega | |||
| Zena Werb | |||
| Thiennu H Vu | |||
| P2860 | cites work | RANK is essential for osteoclast and lymph node development | Q24598872 |
| MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes | Q24628843 | ||
| Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand | Q24644662 | ||
| Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis | Q28140740 | ||
| Perlecan is essential for cartilage and cephalic development | Q28146148 | ||
| Mutation of the matrix metalloproteinase 2 gene (MMP2) causes a multicentric osteolysis and arthritis syndrome | Q28204201 | ||
| Hypoxia in cartilage: HIF-1alpha is essential for chondrocyte growth arrest and survival | Q28363133 | ||
| Critical roles for collagenase-3 (Mmp13) in development of growth plate cartilage and in endochondral ossification | Q28505336 | ||
| Soluble VEGF isoforms are essential for establishing epiphyseal vascularization and regulating chondrocyte development and survival | Q28511090 | ||
| Type I collagen is a genetic modifier of matrix metalloproteinase 2 in murine skeletal development | Q28512977 | ||
| VEGFA is necessary for chondrocyte survival during bone development | Q28590528 | ||
| Transgenic mice with targeted inactivation of the Col2 alpha 1 gene for collagen II develop a skeleton with membranous and periosteal bone but no endochondral bone | Q28591212 | ||
| Galectin-3 is a downstream regulator of matrix metalloproteinase-9 function during endochondral bone formation | Q28595005 | ||
| VEGF receptor 1 signaling is essential for osteoclast development and bone marrow formation in colony-stimulating factor 1-deficient mice | Q34048015 | ||
| Bone development. | Q34059700 | ||
| Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover | Q34075040 | ||
| Merging the old skeletal biology with the new. I. Intramembranous ossification, endochondral ossification, ectopic bone, secondary cartilage, and pathologic considerations | Q34095459 | ||
| Merging the old skeletal biology with the new. II. Molecular aspects of bone formation and bone growth | Q34095465 | ||
| Reaching a genetic and molecular understanding of skeletal development | Q34611297 | ||
| Impaired endochondral ossification and angiogenesis in mice deficient in membrane-type matrix metalloproteinase I | Q35669086 | ||
| Matrix remodeling during endochondral ossification | Q35753177 | ||
| Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities | Q35911056 | ||
| Multiple roles of vascular endothelial growth factor (VEGF) in skeletal development, growth, and repair | Q36005281 | ||
| Molecular mechanisms of endochondral bone development. | Q36032059 | ||
| Cellular and molecular interactions regulating skeletogenesis. | Q36120043 | ||
| Matrix metalloproteinase 9 and vascular endothelial growth factor are essential for osteoclast recruitment into developing long bones | Q36316526 | ||
| MT1-MMP-dependent, apoptotic remodeling of unmineralized cartilage: a critical process in skeletal growth | Q36324816 | ||
| Osteoblastic responses to TGF-beta during bone remodeling | Q36891833 | ||
| RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism | Q37108966 | ||
| A novel matrix metalloproteinase 2 (MMP2) terminal hemopexin domain mutation in a family with multicentric osteolysis with nodulosis and arthritis with cardiac defects | Q37291740 | ||
| Enhanced cleavage of type II collagen by collagenases in osteoarthritic articular cartilage | Q37365557 | ||
| Altered endochondral bone development in matrix metalloproteinase 13-deficient mice | Q37407318 | ||
| Vasculotropin/vascular endothelial growth factor induces differentiation in cultured osteoblasts | Q38310846 | ||
| Regulation of trophoblastic gelatinases by proto-oncogenes | Q38358048 | ||
| Skeletal defects in VEGF(120/120) mice reveal multiple roles for VEGF in skeletogenesis | Q40648372 | ||
| Adenovirus‐mediated VEGF‐A gene transfer induces bone formationin vivo | Q40656016 | ||
| Osteopetrosis in mice lacking haematopoietic transcription factor PU.1. | Q41121255 | ||
| VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochondral bone formation | Q41672985 | ||
| Matrix metalloproteinase-2 regulates vascular patterning and growth affecting tumor cell survival and invasion in GBM. | Q41832788 | ||
| Loss of MMP-2 disrupts skeletal and craniofacial development and results in decreased bone mineralization, joint erosion and defects in osteoblast and osteoclast growth | Q43248379 | ||
| A crucial role for matrix metalloproteinase 2 in osteocytic canalicular formation and bone metabolism | Q46281147 | ||
| Impaired angiogenesis and endochondral bone formation in mice lacking the vascular endothelial growth factor isoforms VEGF164 and VEGF188. | Q46288581 | ||
| Increased bone formation in mice lacking plasminogen activators | Q47768141 | ||
| Conditional inactivation of VEGF-A in areas of collagen2a1 expression results in embryonic lethality in the heterozygous state. | Q52170390 | ||
| The urokinase plasminogen activator (u-PA) and its inhibitor (PAI-1) in embryo-fetal bone formation in the human: an immunohistochemical study. | Q52205646 | ||
| Role of collagen type II and perlecan in skeletal development. | Q53906565 | ||
| The new bone biology: pathologic, molecular, and clinical correlates | Q56334024 | ||
| c-Fos: a key regulator of osteoclast-macrophage lineage determination and bone remodeling | Q58326943 | ||
| The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene | Q59092154 | ||
| Osteopetrosis, a New Recessive Skeletal Mutation on Chromosome 12 of the Mouse | Q67444875 | ||
| MT1-MMP-deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover | Q73082300 | ||
| Vascular endothelial growth factor receptors in osteoclast differentiation and function | Q81073512 | ||
| P433 | issue | 3-4 | |
| P921 | main subject | endothelium | Q111140 |
| P304 | page(s) | 224-235 | |
| P577 | publication date | 2010-02-08 | |
| P1433 | published in | Disease Models & Mechanisms | Q1524006 |
| P1476 | title | Complementary interplay between matrix metalloproteinase-9, vascular endothelial growth factor and osteoclast function drives endochondral bone formation | |
| P478 | volume | 3 |
| Q39372845 | Ablation of Y1 receptor impairs osteoclast bone-resorbing activity |
| Q36493751 | Anti-RANKL treatment inhibits erosive joint destruction and lowers inflammation but has no effect on bone formation in the delayed-type hypersensitivity arthritis (DTHA) model |
| Q28288148 | Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9): the next decade |
| Q26739893 | Blood vessel formation and function in bone |
| Q99561826 | Bone Marrow Microvasculature |
| Q34086663 | Choline kinase beta is required for normal endochondral bone formation |
| Q89964334 | Destroy to Rebuild: The Connection Between Bone Tissue Remodeling and Matrix Metalloproteinases |
| Q42247879 | Dynamics of MMP‑9, MMP‑2 and TIMP‑1 in a rat model of brain injury combined with traumatic heterotopic ossification |
| Q36395889 | Effect of a new formulation of micronized and ultramicronized N-palmitoylethanolamine in a tibia fracture mouse model of complex regional pain syndrome |
| Q48095707 | Effect of tetramethylpyrazine on tibial dyschondroplasia incidence, tibial angiogenesis, performance and characteristics via HIF-1α/VEGF signaling pathway in chickens |
| Q38261860 | Endochondral ossification for enhancing bone regeneration: converging native extracellular matrix biomaterials and developmental engineering in vivo |
| Q37289187 | Epidermal growth factor receptor (EGFR) signaling regulates epiphyseal cartilage development through β-catenin-dependent and -independent pathways |
| Q30579948 | Hck contributes to bone homeostasis by controlling the recruitment of osteoclast precursors |
| Q34346172 | Hypertrophic differentiation of chondrocytes in osteoarthritis: the developmental aspect of degenerative joint disorders |
| Q37572838 | Identification of the vascular endothelial growth factor signalling pathway by quantitative proteomic analysis of rat condylar cartilage |
| Q41834560 | Impaired remodeling phase of fracture repair in the absence of matrix metalloproteinase-2. |
| Q33831246 | Impaired vibration of auditory ossicles in osteopetrotic mice |
| Q36160999 | Kinetics and thermodynamics of irreversible inhibition of matrix metalloproteinase 2 by a Co(III) Schiff base complex |
| Q33689905 | Lysophosphatidic acid enhanced the angiogenic capability of human chondrocytes by regulating Gi/NF-kB-dependent angiogenic factor expression |
| Q42383995 | MMP9 regulates the cellular response to inflammation after skeletal injury |
| Q39564990 | Measuring matrix metalloproteinase activity in macrophages and polymorphonuclear leukocytes |
| Q84744195 | Monitoring mmp-9 gene expression in stromal cells using a novel transgenic mouse model |
| Q38230878 | Origin and functions of tissue macrophages. |
| Q39197756 | Over-expression of VEGF and MMP-9 in residual tumor cells of hepatocellular carcinoma after embolization with lipidol |
| Q26827481 | Overview of biological mechanisms and applications of three murine models of bone repair: closed fracture with intramedullary fixation, distraction osteogenesis, and marrow ablation by reaming |
| Q55082811 | Paracrine and endocrine actions of bone-the functions of secretory proteins from osteoblasts, osteocytes, and osteoclasts. |
| Q38219247 | Recapitulating endochondral ossification: a promising route to in vivo bone regeneration |
| Q85832382 | Regression of an enchondroma: a case report and proposed etiology |
| Q38071918 | Role and regulation of vascularization processes in endochondral bones |
| Q39945937 | Role of myeloid early endothelial progenitor cells in bone formation and osteoclast differentiation in tissue construct based on hydroxyapatite poly(ester-urethane) scaffolds |
| Q38810753 | The critical role of the epidermal growth factor receptor in endochondral ossification. |
| Q89579537 | The hypoxic microenvironment: a driving force for heterotopic ossification progression |
| Q50651156 | The mineral dissolution function of osteoclasts is dispensable for hypertrophic cartilage degradation during long bone development and growth. |
| Q39408957 | The traumatic bone: trauma-induced heterotopic ossification. |
| Q51248427 | Vascular Canals in Permanent Hyaline Cartilage: Development, Corrosion of Nonmineralized Cartilage Matrix, and Removal of Matrix Degradation Products. |
| Q36497720 | c-Raf promotes angiogenesis during normal growth plate maturation |
| Q37381251 | β-catenin activity in late hypertrophic chondrocytes locally orchestrates osteoblastogenesis and osteoclastogenesis |
Search more.